Drawing for ONO

USPTO serial 79379120

ONO

Reviewed by CopyMark Law Group

Reg. 7464726Status 700Registered
Filing date
Status date
Registration date
Aug 6, 2024
Examiner
CANTONE, KERI H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Perla M. Kuhn

Perla M. Kuhn Fox Rothschild LLP997 Lenox Drive, Building 3Princeton Pike Corporate CenterLawrenceville, NJ 08648-2311

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes for treating cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; general and topical anesthetic, sedative and analgesic drugs; vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 22, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 20, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 20, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 31, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 31, 2025FIMPFINAL DISPOSITION PROCESSED—
Nov 7, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 6, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 6, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 15, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 15, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 15, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 30, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 30, 2023RFRRREFUSAL PROCESSED BY MPU—
Oct 27, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 26, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2023DOCKASSIGNED TO EXAMINER—
Oct 3, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 21, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance